2021 年 8 月 2 日

Industry Veteran Joins Calyx to Advance IRT Solutions and Services

Craig Mooney leveraging 30 years’ industry experience to optimize eClinical trial technology delivery

Nottingham, England and Morrisville, NC – 2021 年 8 月 2 日 Calyx, the eClinical and Regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced that Craig M. Mooney has joined the company as Vice President of Scientific E-tech Enabled Services. Mooney has nearly 30 years’ experience in the clinical development industry, with concentrated focus on optimizing IRT to improve clinical trial efficiencies.

Craig M. Mooney, VP, Scientific E-tech Enabled Services

“Craig brings a unique understanding of IRT from both a delivery and user perspective, which we believe will be a great benefit to our global pharmaceutical and CRO clients,” said Dr. Stephen Bravo, Chief Medical Officer of Calyx. “We’re delighted to have him join our team.”

Mooney comes to Calyx from Bristol-Myers Squibb, where he served as the Director of IRT for most of the past decade. In his role at Calyx, he will shape the company’s eClinical technology development pipeline and consult with its customers on optimizing IRT to improve operational efficiencies and meet study and regulatory requirements.

“Since Calyx became its own entity, I’ve watched them aggressively invest in hiring experts with well-honed skills and fresh viewpoints to ensure their solutions and services meet the needs of the industry,” said Mooney. “I see the company as the perfect blend of entrepreneurial creativity and the expertise that only comes with a long history of experience and success, and I’m thrilled to join the team.”

如需了解更多信息,请访问 Calyx.ai

关于凯理斯

通过创新的 eClinical 解决方案和服务,凯理斯使不确定转为可靠,从而帮助将新的医疗方法更快地推向市场。凭借在临床开发方面的深厚专业知识以及在支持试验申办方和临床研究组织 (CRO) 方面逾 25 年的经验,凯理斯利用这种才智并激发其解决复杂问题的潜力,提供快速见解并每天都将新药推向市场。

CTMS | EDC | IRT | 医学影像 | RIM

如需了解有关如何使您的试验进展得更深入和更快的信息,请访问 calyx.ai、LinkedInTwitterFacebook

媒体联系人:

Christine Tobin | [电子邮件地址受保护] |+1 412-628-8598


获取最新消息

不错过任何精彩内容。立即注册,接收涵盖行业新闻和其他相关信息的电子邮件,帮助您推进临床开发。

  • 此字段用于验证目的,应保持不变。
Powered by Translations.com GlobalLink OneLink Software